PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 15 filers reported holding PTC THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 2.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $3,951,000 | +115.7% | 4,000,000 | +100.0% | 0.00% | 0.0% |
Q1 2018 | $1,832,000 | +388.5% | 2,000,000 | +312.4% | 0.00% | – |
Q2 2017 | $375,000 | +77.7% | 485,000 | +44.3% | 0.00% | – |
Q1 2017 | $211,000 | -73.5% | 336,000 | -74.9% | 0.00% | -100.0% |
Q4 2016 | $795,000 | -74.2% | 1,336,000 | -77.0% | 0.00% | -50.0% |
Q3 2016 | $3,077,000 | – | 5,807,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 24,877,000 | $28,400,000 | 0.91% |
DeepCurrents Investment Group LLC | 11,130,000 | $12,770,000 | 0.58% |
FARALLON CAPITAL MANAGEMENT LLC | 39,676,000 | $45,851,000 | 0.31% |
WOLVERINE ASSET MANAGEMENT LLC | 20,454,000 | $23,593,000 | 0.27% |
PALISADE CAPITAL MANAGEMENT, LP | 2,300,000 | $2,645,000 | 0.08% |
Verition Fund Management LLC | 2,762,000 | $3,197,000 | 0.06% |
LOOMIS SAYLES & CO L P | 240,850 | $11,568,000 | 0.02% |
Allianz Asset Management GmbH | 16,525,000 | $19,009,000 | 0.02% |
D. E. Shaw & Co., Inc. | 8,443,000 | $9,732,000 | 0.01% |
CREDIT SUISSE AG/ | 12,393,000 | $14,296,000 | 0.01% |